School of Medicine
Showing 1-50 of 50 Results
-
Jason Andrews
Assistant Professor of Medicine (Infectious Diseases) and, by courtesy, of Health Research and Policy (Epidemiology)
Current Research and Scholarly Interests Our laboratory aims to develop and test innovative approaches to the diagnosis, treatment and control of infectious diseases in resource-limited settings. We draw upon multiple fields including mathematical modeling, microbial genetics, field epidemiology, statistical inference and biodesign to work on challenging problems in infectious diseases, with an emphasis on tuberculosis and tropical diseases.
-
Niaz Banaei
Associate Professor of Pathology and of Medicine (Infectious Diseases) at the Stanford University Medical Center
Current Research and Scholarly Interests His research interests include (1) development, assessment, and improvement of novel infectious diseases diagnostics, (2) enhancing the quality of C. difficile diagnostic results, and (3) characterization of M. tuberculosis virulence determinants.
-
Brian Blackburn
Clinical Associate Professor, Medicine - Infectious Diseases
Current Research and Scholarly Interests My interests include parasitology and global health; I've investigated cryptosporidium and angiostrongylus outbreaks; schistosoma/strongyloides seroprevalence in refugees, and the distribution and impact of ITNs for malaria and filariasis prevention in Nigeria and India. I have done clinical and programmatic work at teaching hospitals in Liberia and Bangladesh and have opportunities for research in Bangladesh and Kenya, in collaboration with ICDDR,B and CDC, Kenya
-
Catherine Blish
Associate Professor of Medicine (Infectious Diseases)
Current Research and Scholarly Interests The major goal of our research is to gain insight into the prevention and control of HIV and other viral pathogens by studying the interplay between the virus and the host immune response. We investigate the role of various arms of the immune response, but with a particular focus on NK cells. We hope to gain additional insights into control of infectious diseases by studying how pregnancy modulates immune responses.
-
Paul Bollyky
Assistant Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly Interests Our lab studies how immune responses are regulated within inflamed or infected tissues. We welcome research students with interests in immunology, structural biology, and microbiology.
-
Hector Fabio Bonilla
Clinical Assistant Professor, Medicine - Infectious Diseases
Bio As a young physician at Louisiana State University, Dr. Bonilla focused on the Clinical Management of HIV/AIDS and HCV, two neglected and stigmatized diseases for which effective therapies were in their infancy. While learning the clinical aspects of the two diseases, Dr. Bonilla saw a need to create and organize a support community to promote understanding and management of the conditions. Subsequently, he went to Summa Health System in Akron, Ohio, and he continued his work where he specialized in HIV/HCV as well as in Infectious Diseases Clinical Practice. In addition to teaching medical residents and students, Dr. Bonilla participated in numerous clinical trials and developed clinical research projects. Furthermore, he led the Infection Renal Transplant Program, HIV and HCV clinics, and he participated in several cooperative studies with Case Western Reserve University. Dr. Bonilla?s interest in academia led him to the University Of Pittsburgh Medical Center where he was an Assistant Professor, Clinician, and Medical Educator in the Department of Medicine in the Division of Infectious Diseases. Due to his interest in cytokines and immunological responses, Dr. Bonilla became a researcher at ImmunoScience Inc., a biotechnology company in California that works to develop a therapeutic HIV vaccine. Dr. Bonilla?s experience of treating HIV/HCV combined with his interest in inflammatory response is the driving force behind his desire to understand ME/CFS. Dr. Bonilla is a strong patient advocate, and he believes in integrated care?care in which physicians communicate and coordinate efforts to deliver the best medical outcome for patients. His ME/CFS patients are his inspiration, and he is committed to continuing research to seek answers to their health challenges.
-
Stanley Deresinski
Clinical Professor, Medicine - Infectious Diseases
Bio Dr. Deresinski received his medical degree from the University of Illinois College of Medicine and received training in Internal Medicine there and at Stanford, where he also completed a fellowship in Infectious Diseases. For 3 decades, he maintained a private practice in Infectious Disease, HIV, and Travel Medicine and was Hospital Epidemiologist at Sequoia Hospital where he also served as President of the Medical Staff for 2 years. He was also Associate Chief of the Division of Infectious Diseases and for 14 years was Director of the AIDS Program at the Santa Valley Medical Center, a Stanford-affiliated public teaching hospital. During that time he won several teaching awards at Stanford. In 1987, he founded the AIDS Community Research Consortium, serving as its Medical Director and Chairman of the Board for almost 2 decades. He was also Site Principal Investigator for the Stanford ACTU and the California Collaborative Treatment Group and has worked on AIDS education in Kampala, Uganda. Dr. Deresinski is currently Clinical Professor of Medicine in the Division of Infectious Diseases and Geographic Medicine at Stanford and is Medical Director of the Stanford Antimicrobial Stewardship Program and Chair of the Pharmacy and Therapeutics Committee and of the Specialty Drugs Subcommittee. He has special interests in antimicrobial resistance, optimal antimicrobial use, fungal infections, and infections in immunocomopromised hosts.
Dr. Deresinski has published more than 100 peer-reviewed papers as well as number of book chapters. He is a Section Editor of Clinical Infectious Diseases and is a past Chair of the Infectious Diseases Society of America (IDSA) Standards and Practice Guidelines Committee as well as member of the IDSA Board of Directors. He is a member of the HIVMA, in addition to a number of other societies including SHEA and is a Fellow in the American College of Physicians as well as IDSA. He is a past winner of the IDSA Watanakunokorn Clinician of the YearAward. -
Daniel DiGiulio
Clinical Instructor, Medicine - Infectious Diseases
Current Research and Scholarly Interests My research uses cultivation-independent methods to investigate human-associated microbiota during health and disease. This work exploits high-throughput molecular approaches to characterize stereotypic patterns of microbial prevalence, diversity and abundance associated with specific clinical syndromes of interest. I am especially interested in identifying and enumerating cultivation-resistant pathogens causing cryptic infections, particularly intra-amniotic infections leading to preterm birth.
-
Shirit Einav
Associate Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly Interests My lab's goals are to better understand virus-host protein interactions, identify host partners conservatively required by multiple viruses, and develop broad-spectrum host-centered antiviral approaches with a high genetic barrier for resistance. We combine novel proteomic approaches, including microfluidics platforms, with molecular virology, biochemical, and genomic approaches to achieve these goals. We focus on viruses from the Flaviviridae family (hepatitis C and dengue), as well as HIV.
-
Philip Grant
Assistant Professor of Medicine (Infectious Diseases) at the Stanford University Medical Center
Bio My research focuses on antiretroviral therapy and complications of HIV including immune reconstitution inflammatory disease, osteoporosis, and cardiovascular disease.
-
Dora Ho
Clinical Associate Professor, Medicine - Infectious Diseases
Current Research and Scholarly Interests Dr. Ho did her PhD work in HSV pathogenesis and postdoctoral research in CNS gene therapy with viral vectors. She is currently the clinical chief of the Division of Infectious Diseases and Geographic Medicine. She specializes in infection complications of immunocompromised patients, such as those with cancers, solid organ transplant or bone marrow transplant.
-
Mark Holodniy
Professor of Medicine (Infectious Diseases) at the Palo Alto Veterans Affairs Health Care System
Current Research and Scholarly Interests My research program is currently focused in three areas: 1) Translational research (HCV/HIV viral evolution and antiviral resistance prevalence and development), 2) Clinical trials (diagnostic assay/medical device, antimicrobials and immunomodulators), and 3) Health services research focusing on cost effectiveness of antiviral utilization and clincal outcomes.
-
Marisa Holubar
Clinical Assistant Professor, Medicine - Infectious Diseases
Bio Dr. Marisa Holubar specializes in the treatment of infectious diseases and works primarily in the inpatient setting. She is particularly interested in antimicrobial stewardship and hospital epidemiology.
-
Prasanna Jagannathan
Assistant Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
Bio I am an Infectious Diseases specialist with a research program in translational immunology focused on malaria-specific immune responses in pregnancy and infancy. My current research program is to further our understanding of the mechanisms of clinical immunity to malaria through field-based studies, and to better understand the immunologic consequences of malaria control interventions.
-
Shanthi Kappagoda
Clinical Assistant Professor, Medicine - Infectious Diseases
Current Research and Scholarly Interests Completed a Masters degree in Health Services Research in 2012. Research focused on using network models to develop a clinical research agenda for neglected tropical diseases.
-
David Katzenstein
Professor (Research) of Medicine (Infectious Diseases and Geographic Medicine), Emeritus
Current Research and Scholarly Interests Treatment and evaluation of HIV infectionin the United States and Europe through the AIDS Clinical Trials Group (ACTG). International HIV pathogenesis work includes studies in Zimbabwe, South Africa, and India where we are particularly interested in the pandemic of subtype C HIV-1, TB and other co-infections. The lab currently is focused on drug resistance, envelope tropism and the pathogenesis of HIV.
-
Stephen Luby
Professor of Medicine (Infectious Diseases) and Senior Fellow at the Woods Institute and the Freeman Spogli Institute and Professor, by courtesy, of Health Research and Policy (Epidemiology)
Current Research and Scholarly Interests Dr. Luby?s research interests include identifying and interrupting pathways of infectious disease transmission in low income countries. He works primarily in Bangladesh.
-
Thomas Charles Merigan M.D.
George E. and Lucy Becker Professor of Medicine, Emeritus
Current Research and Scholarly Interests I am now emeritus and only participate in university activities through advising my former trainees who have joined the faculty.
-
Joanna Nelson
Clinical Assistant Professor, Medicine - Infectious Diseases
Bio Dr. Nelson is a board certified Infectious Disease specialist. She specializes in the treatment of immunocompromised patients, including patients who have had solid organ or bone marrow transplantation or who have malignancy undergoing chemotherapy. She also has a special interest in caring for patients with Cystic fibrosis or who have had a lung transplant as well as Nontuberculous mycobacterial Infections.
-
Andrew Nevins
Clinical Associate Professor, Medicine - Infectious Diseases
Current Research and Scholarly Interests Clinical general infectious diseases. Medical education.
-
John Openshaw
Instructor, Medicine - Infectious Diseases
Current Research and Scholarly Interests My current work aims to detect viral spillover events from animals to humans with the hope of eventually understanding the ecology that drives this process and better defining the steps that will be required to stop the emergence of these pathogens.
-
Julie Parsonnet
George DeForest Barnett Professor in Medicine and Professor of Health Research and Policy (Epidemiology)
Current Research and Scholarly Interests I am an infectious diseases epidemiologist who has done large field studies in both the US and developing countries. We research the long-term consequences of chronic interactions between the human host and the microbial world. My lab has done fundamental work establishing the role of H. pylori in causing disease and understanding its epidemiology. Currently, our research dissects how and when children first encounter microbes and the long term effects of these exposures on health.
-
Benjamin Pinsky
Associate Professor of Pathology and of Medicine (Infectious Diseases) and, by courtesy, of Pediatrics (Infectious Diseases) at the Stanford University Medical Center
Current Research and Scholarly Interests Development and application of molecular assays for the diagnosis and management of infectious diseases.
-
David A. Relman
Thomas C. and Joan M. Merigan Professor and Professor of Microbiology and Immunology
Current Research and Scholarly Interests My investigative program focuses on human-microbe interactions and human microbial ecology, and primarily concerns the ecology of human indigenous microbial communities; a secondary interest concerns the classification of humans with systemic infectious diseases, based on features of genome-wide gene transcript abundance patterns and pther aspects of the host response.
-
Gary Schoolnik
Professor of Medicine (Infectious Diseases), Emeritus
Current Research and Scholarly Interests Structure-function analysis of bacterial adhesion proteins and toxins; design and synthesis of synthetic antigens; immunobiology of human papillomaviruses
-
Robert W. Shafer
Professor (Research) of Medicine (Infectious Diseases) and, by courtesy, of Pathology
Current Research and Scholarly Interests My group?s research is on the mechanisms and consequences of virus evolution with a focus on HIV therapy and drug resistance. We maintain a public HIV drug resistance database (http://hivdb.stanford.edu) as a resource for HIV drug resistance surveillance, interpreting HIV drug resistance tests, and HIV drug development. Our paramount goal is to inform HIV treatment and prevention policies by identifying the main factors responsible for the emergence and spread of drug resistance.
-
Upinder Singh
Professor of Medicine (Infectious Diseases & Geographic Medicine) and of Microbiology and Immunology
Current Research and Scholarly Interests Our lab elucidates the molecular basis of pathogenesis of the protozoan parasite Entamoeba histolytica. We use genetic and genomic approaches to identify novel virulence determinants and to characterize the global epidemiology of the parasite.
-
David A. Stevens
Professor of Medicine, Emeritus
Current Research and Scholarly Interests Immunology and chemotherapy of human fungal diseases, particularly coccidioidomycosis (Valley Fever) in California and aspergillosis.
-
Aruna Subramanian
Clinical Professor, Medicine - Infectious Diseases
Current Research and Scholarly Interests My research and scholarly interests have focused on tailoring antimicrobial prophylaxis in specific highly immunocompromised hosts depending on their specific infectious disease risks. I am interested in developing diagnostic algorithms and treatment protocols that will improve the quality of care in transplant and oncology patients.
I also have an interest in training ID fellows in this very specialized area of patient care. To that end, we have started a new ICHS ID fellowship with a specialized curriculum and are developing supplemental educational materials to enhance this training, which can be implemented at other academic training centers. -
Lucy Tompkins
Lucy Becker Professor in Medicine and of Microbiology and Immunology
Current Research and Scholarly Interests Genetic and cellular basis of pathogenicity of Helicobacter pylori. Molecular epidemiology, hospital epidemiology, quality improvement in healthcare associated infections.
-
Elena Vendrame
Instructor, Medicine - Infectious Diseases
Current Research and Scholarly Interests My research focuses on understanding the host-pathogen interactions. In particular I study the interaction between natural killer cells and HIV.
-
Wang,Taia
Assistant Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly Interests Studies in our lab are aimed at defining mechanisms in human immunity and disease. We are particularly interested the hypothesis that IgG repertoire diversity is a central driver of heterogeneity in human immune functioning and susceptibility to infectious diseases. Our work is defining how diversity that exists in the IgG Fc domain repertoire among people, which we define by serum IgG subclass and Fc glycoform distributions, impacts immune processes such as vaccine responses and susceptibility to antibody-dependent enhancement of dengue disease (Wang TT, Cell. 2015 and Wang TT, Science. 2017). IgG subclass and Fc glycoform distributions are key regulators of immunity because these determine the structure of Fc domains within immune complexes that form during vaccination or infection. Fc structure, in turn, determines the affinity of immune complexes for various Fc receptors on effector cells. Thus, we are studying how the Fc domain repertoire of an individual impacts the quality of effector cell responses that can be recruited during immune activation and how selectivity of effector responses contributes to immunity and disease.
We are particularly interested in training students and postdocs who will go on to be independent investigators in mechanistic studies relevant to human disease.
Current clinical studies:
Recruiting:
An Open Label Study of IgG Fc Glycan Composition in Human Immunity
Principal Investigator: Taia T. Wang, MD, PhD
ClinicalTrials.gov Identifier:
NCT01967238 -
Andrew Zolopa
Professor of Medicine (Infectious Diseases) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly Interests Dr. Zolopa’s research applies a variety of clinical epidemiologic methods in an effort to optimize antiretroviral therapy and understand the impact of drug resistance on response to ARV. Areas of focus include the clinical application of resistance testing in optimizing antiretroviral therapy, clinical cohorts, trials of antiretroviral therapies and population-based epidemiologic evaluation of HIV resistance and efficacy of ARV therapy. More recently studies focused on premature aging in HIV.
